3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
15
Lymphoma, Large B-Cell, Diffuse
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Prostatic Neoplasms
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Biphenotypic, Acute
4
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Melanoma
2
Carcinoma, Merkel Cell
2
Carcinoma, Basal Cell
2
Plasmablastic Lymphoma
1
Multiple Myeloma
1
Lymphoma, T-Cell
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma, B-Cell
1
Lymphoma, AIDS-Related
1
Lymphoma
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Leukemia, Myeloid, Accelerated Phase
1
HTLV-I Infections
1
Down Syndrome
1
Blastic Plasmacytoid Dendritic Cell Neoplasm
1
Blast Crisis
1
Ann Arbor Stage II Mantle Cell Lymphoma
1
Interventions
rozanolixizumab
5
ravulizumab
5
zilucoplan
4
fludarabine
3
Cyclophosphamide
3
telitacicept
2
inebilizumab
2
talquetamab
1
remibrutinib
1
iptacopan
1
efgartigimod alfa
1
Therapeutics
1
Prednisone
1
Prednisolone
1
Plasma Exchange
1
Immunoglobulins, Intravenous
1
HBM9161
1
Cladribine
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myasthenia Gravis
×
deltacortene
×
90 days
×
Clear all
No trials found.